title: Predicting the clinical course of Hodgkin lymphoma.
authors.forename: Alberto
authors.initials: A
authors.lastname: Fabbri
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gozzetti
authors.forename: Francesco
authors.initials: F
authors.lastname: Forconi
authors.forename: Francesco
authors.initials: F
authors.lastname: Lauria
mesh_terms: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D018450:Disease Progression; D019788:Fluorodeoxyglucose F18; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007150:Immunohistochemistry; D008264:Macrophages / Q000276:immunology; D049268:Positron-Emission Tomography; D011379:Prognosis; D016896:Treatment Outcome; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D014408:Biomarkers, Tumor; D019788:Fluorodeoxyglucose F18; C067980:CD68 antigen, human; D000097382:CD68 Molecule